Methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin gene from a pediatric hospital in

Bahija Serray1, Mohammed Sobh1, Mohammed Timinouni2

  • 1Laboratory of Microbiology, Pharmacology, Biotechnology, and Environment, Faculty of Sciences Ain-Chock, Casablanca, Morocco.

Abstract

Insights

A study in Marrakech found only 1.89% of pediatric Methicillin-resistant Staphylococcus aureus (MRSA) isolates carried the Panton-Valentine leukocidin (PVL) gene. This low prevalence highlights the need for ongoing surveillance of PVL-positive MRSA in children.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to rising antibiotic resistance.
  • Panton-Valentine leukocidin (PVL) is a key MRSA virulence factor responsible for severe tissue damage.
  • Combating resistant bacterial infections requires understanding the prevalence of specific virulence factors.

Purpose of the Study:

  • To determine the frequency of pvl-positive MRSA in a pediatric hospital in Marrakech, Morocco.
  • To assess the potential risk associated with PVL-producing MRSA in a vulnerable pediatric population.
  • To inform infection control strategies by characterizing MRSA strains.

Main Methods:

  • Collected 53 MRSA isolates from pediatric clinical specimens between December 2010 and May 2014.
  • Confirmed MRSA using biochemical tests (coagulase, mannitol fermentation, DNase).
  • Utilized polymerase chain reaction (PCR) to detect the presence of the pvl gene.

Main Results:

  • Out of 259 Staphylococcus aureus isolates, 53 were identified as MRSA.
  • Only 1 MRSA isolate (1.89%) tested positive for the pvl gene.
  • The single pvl-positive MRSA isolate was identified as SCCmec IV, typical of community-acquired infections.

Conclusions:

  • PVL-positive MRSA exhibited a low prevalence (1.89%) in the studied pediatric hospital population.
  • The presence of PVL-positive MRSA, even at low rates, indicates a potential risk for severe pediatric infections.
  • Continuous surveillance and robust infection control are crucial to manage MRSA spread and associated risks.